Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Gmo Labeling topic
No spam. Unsubscribe anytime.
Sponsor urges state role on genetically engineered labeling even as federal rule now sets disclosure standard
Summary
Representative Cindy Quint reintroduced a measure to reassert state authority for labeling genetically engineered foods and to prompt discussion of evolving biotechnology in the food supply; DACF explained the National Bioengineered Food Disclosure Standard and upcoming mandatory compliance dates.
Representative Cindy Quint presented LD 12 57, a bill intended to renew legislative attention to labeling of genetically engineered (now described in federal law as “bioengineered”) food products. Quint said many Mainers want clearer disclosures on ingredients and growing technologies, and raised questions about new developments—cloned or cell‑cultured meat, mRNA technologies and patented bioengineered organisms—and how the state should respond.
Federal preemption and agency testimony: Multiple agency witnesses clarified that the National Bioengineered Food Disclosure Standard, passed by Congress in 2016, directs USDA to establish a national mandatory disclosure mechanism and preempts state labeling systems that are not identical. DACF and the deputy DAFS witness briefed the committee: USDA’s disclosure rules were finalized and updated; mandatory compliance is scheduled to begin June 23, 2025. DACF explained the federal definition of “bioengineered” aligns with Maine’s earlier statutory language for “genetically engineered” and said many processed items are exempted or may qualify for a QR‑code style disclosure under the federal standard.
Public testimony: Consumer advocates and family members testified in support. Representative Laurie Perkins described family members with a reported severe reaction to genetically engineered corn and urged stronger labeling to protect people with sensitivities. MOFGA supported consumer right‑to‑know but noted federal preemption limits state authority and encouraged consumers to rely on certified organic labeling where appropriate.
Committee questions and path forward: Lawmakers asked DACF to provide additional federal rule details, including the current list of bioengineered foods and how lab‑grown or cloned products are handled under federal law. DACF noted that some items (for example, certain bioengineered fish) already carry required federal disclosures and that lab‑grown/cultured meat products are regulated by FDA/USDA but do not fall under the bioengineered definition. The committee took no vote and requested follow‑up information for the work session.
